Since PSMA exhibits high affinity with PSMA-targeting molecular probes, PSMA ligand-targeted PET imaging has significant advantages in the diagnosis, staging, follow-up and prognostic evaluation of PCa (Hofman et al. 2020; Koerber et al. 2017). The gene discussed is FOLH1; the disease is posterior cortical atrophy.